The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity

Bossi Paolo, Cossu Rocca Maria, Corvò Renzo, Depenni Roberta, Guardamagna Vittorio, Marinangeli Franco, Miccichè Francesco, Trippa Fabio

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The intensity of the available treatment approaches for locally-advanced head and neck cancer (HNC) is at the upper limit of tolerance of acute toxicities. Several factors including breakthrough cancer pain, mucositis, dysphagia, local and systemic infections, and nutritional problems are related to treatment intensity. Particularly, pain, as symptom directly associated with the disease or combined with other treatment-related factors, has a major impact on quality of life of HNC patients and ultimately can influence the efficacy of treatments in HNC. Here, a Multidisciplinary Board of Italian Experts has addressed these issues, with the aim to identify the unmet need and appropriate strategies for the maintenance of optimal treatment intensity in HNC.

Original languageEnglish
Pages (from-to)82-88
Number of pages7
JournalCritical Reviews in Oncology/Hematology
Volume116
DOIs
Publication statusPublished - Aug 1 2017

Fingerprint

Head and Neck Neoplasms
Breakthrough Pain
Mucositis
Therapeutics
Deglutition Disorders
Quality of Life
Pain
Infection

Keywords

  • Breakthrough cancer pain
  • Concurrent chemoradiotherapy
  • Dysphagia
  • Head and neck cancer
  • Mucositis
  • Quality of life
  • Treatment intensity

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Geriatrics and Gerontology

Cite this

The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity. / Paolo, Bossi; Maria, Cossu Rocca; Renzo, Corvò; Roberta, Depenni; Vittorio, Guardamagna; Franco, Marinangeli; Francesco, Miccichè; Fabio, Trippa.

In: Critical Reviews in Oncology/Hematology, Vol. 116, 01.08.2017, p. 82-88.

Research output: Contribution to journalReview article

Paolo, Bossi ; Maria, Cossu Rocca ; Renzo, Corvò ; Roberta, Depenni ; Vittorio, Guardamagna ; Franco, Marinangeli ; Francesco, Miccichè ; Fabio, Trippa. / The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity. In: Critical Reviews in Oncology/Hematology. 2017 ; Vol. 116. pp. 82-88.
@article{f67244094c6443d7898ea9a668cb1c96,
title = "The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity",
abstract = "The intensity of the available treatment approaches for locally-advanced head and neck cancer (HNC) is at the upper limit of tolerance of acute toxicities. Several factors including breakthrough cancer pain, mucositis, dysphagia, local and systemic infections, and nutritional problems are related to treatment intensity. Particularly, pain, as symptom directly associated with the disease or combined with other treatment-related factors, has a major impact on quality of life of HNC patients and ultimately can influence the efficacy of treatments in HNC. Here, a Multidisciplinary Board of Italian Experts has addressed these issues, with the aim to identify the unmet need and appropriate strategies for the maintenance of optimal treatment intensity in HNC.",
keywords = "Breakthrough cancer pain, Concurrent chemoradiotherapy, Dysphagia, Head and neck cancer, Mucositis, Quality of life, Treatment intensity",
author = "Bossi Paolo and Maria, {Cossu Rocca} and Corv{\`o} Renzo and Depenni Roberta and Guardamagna Vittorio and Marinangeli Franco and Miccich{\`e} Francesco and Trippa Fabio",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.critrevonc.2017.05.012",
language = "English",
volume = "116",
pages = "82--88",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity

AU - Paolo, Bossi

AU - Maria, Cossu Rocca

AU - Renzo, Corvò

AU - Roberta, Depenni

AU - Vittorio, Guardamagna

AU - Franco, Marinangeli

AU - Francesco, Miccichè

AU - Fabio, Trippa

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The intensity of the available treatment approaches for locally-advanced head and neck cancer (HNC) is at the upper limit of tolerance of acute toxicities. Several factors including breakthrough cancer pain, mucositis, dysphagia, local and systemic infections, and nutritional problems are related to treatment intensity. Particularly, pain, as symptom directly associated with the disease or combined with other treatment-related factors, has a major impact on quality of life of HNC patients and ultimately can influence the efficacy of treatments in HNC. Here, a Multidisciplinary Board of Italian Experts has addressed these issues, with the aim to identify the unmet need and appropriate strategies for the maintenance of optimal treatment intensity in HNC.

AB - The intensity of the available treatment approaches for locally-advanced head and neck cancer (HNC) is at the upper limit of tolerance of acute toxicities. Several factors including breakthrough cancer pain, mucositis, dysphagia, local and systemic infections, and nutritional problems are related to treatment intensity. Particularly, pain, as symptom directly associated with the disease or combined with other treatment-related factors, has a major impact on quality of life of HNC patients and ultimately can influence the efficacy of treatments in HNC. Here, a Multidisciplinary Board of Italian Experts has addressed these issues, with the aim to identify the unmet need and appropriate strategies for the maintenance of optimal treatment intensity in HNC.

KW - Breakthrough cancer pain

KW - Concurrent chemoradiotherapy

KW - Dysphagia

KW - Head and neck cancer

KW - Mucositis

KW - Quality of life

KW - Treatment intensity

UR - http://www.scopus.com/inward/record.url?scp=85024829759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024829759&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2017.05.012

DO - 10.1016/j.critrevonc.2017.05.012

M3 - Review article

VL - 116

SP - 82

EP - 88

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -